Results 41 to 50 of about 6,509 (249)

A comparative evaluation of the efficacy and safety of Latanoprost-Optic and Xalatan used as monotherapy and combined with Dorzolamide-Optic for primary open-angle glaucoma under clinical practice conditions

Российский офтальмологический журнал, 2023
The number of ophthalmic antihypertensive drugs available in Russia is steadily increasing, which complicates the choice to be made by ophthalmologist practitioners.
D. P. Novikov, O. A. Frolov, A. S. Pokrovsky, V. V. Novikova   +3 more
doaj   +1 more source

24-h Efficacy of Glaucoma Treatment Options [PDF]

, 2016
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss.
Banu, Bozkurt., Garcia-Feijoo, Julian, Katsanos, Andreas, Konstas, Anastasios, Miglior, Stefano, Pfeiffer, Norbert, Quaranta, Luciano, Rossetti, Luca, Shaarawy, Tarek   +8 more
core   +1 more source

Visual field testing and glaucoma drug prescribing patterns in Australia

Ophthalmic and Physiological Optics, EarlyView.
Abstract Purpose To examine glaucoma practice patterns in Australia, focusing on visual field test uptake and antiglaucoma drug prescribing by optometrists and ophthalmologists. Design A serial cross‐sectional study was conducted to describe visual field testing charges and compare them to changes in comprehensive eye examination charges, as well as to
Catherine L. Jan, Algis Vingrys, Randall S. Stafford, Mengtian Kang, Xianwen Shang, Wenyi Hu, Jiahao Liu, Sanil Joseph, Mingguang He   +8 more
wiley   +1 more source

Acute serous and hemorrhagic choroidal effusion associated with topical dorzolamide therapy

American Journal of Ophthalmology Case Reports, 2023
Purpose: To report a case of acute onset unilateral hemorrhagic and serous choroidal effusion associated with dorzolamide administration and antiplatelet use that recurred in a patient who experienced a dorzolamide-induced choroidal effusion ten years ...
Abdulla Shaheen, Sara Schultis, Maria Magraner, Zelia M. Correa, Nicolas A. Yannuzzi, David S. Greenfield   +5 more
doaj  

Short-term effects of ocular 2% dorzolamide, 0.5% timolol or 0.005% latanoprost on the anterior segment architecture in healthy cats: a prospective study. [PDF]

, 2020
International audienceDorzolamide 2%, timolol 0.5% and latanoprost 0.005% are widely used in the medical management of glaucoma in humans and pets.
Balland, Olivier, Barbry, Jean-Baptiste, Bastogne, Thierry, Poinsard, Anne-Sophie   +3 more
core   +1 more source

Effects of intracameral tissue plasminogen activator injection on posterior capsular opacification, fibrin formation, and intraocular pressure in dogs after phacoemulsification

Veterinary Ophthalmology, EarlyView.
Abstract Objective To evaluate whether intracameral tissue plasminogen activator (tPA) injection is effective in regulating posterior capsular opacification (PCO), fibrin formation and intraocular pressure (IOP) after cataract surgery. Animal Studied Prospective study involving 30 eyes of 21 dogs that underwent phacoemulsification.
Kyulee Kim, Young‐Sun Kang, Joon Young Kim   +2 more
wiley   +1 more source

Synthesis of Novel Isoindolinones: Carbonic Anhydrase Inhibition Profiles, Antioxidant Potential, Antimicrobial Effect, Cytotoxicity and Anticancer Activity

Journal of Biochemical and Molecular Toxicology, Volume 39, Issue 4, April 2025.
Highly effective one‐pot synthesis of novel isoindolinones Inhibitory, antioxidant, antimicrobial cytotoxicity, and anticancer potentials of synthesized novel isoindolinone derivatives were investigated. ABSTRACT An efficient one‐pot method has been developed for synthesizing novel isoindolinone derivatives from 2‐benzoylbenzoic acid using ...
Yusuf Serdar Yazıcıoğlu, Şeydanur Elmas, Zeynep Kılıç, Murat Çelik, Buket Bakan, Ufuk Atmaca, Songül Bayrak   +6 more
wiley   +1 more source

Pharmaceutical treatment of primary open angle glaucoma [PDF]

, 2021
Background: Glaucoma is a progressive, irreversible optic neuropathy that results in serious vision loss and blindness. This review aimed to summarize key concepts of primary open angle glaucoma (POAG) pharmaceutical treatment trials over the last decade.
Al-Namaeh , Mashael
core   +2 more sources

Barriers and Facilitators to Medicines Use in Patients With Vision Impairment: A Theory‐Informed Qualitative Study of Patients and Caregivers

Health Expectations, Volume 28, Issue 2, April 2025.
ABSTRACT Introduction Previous studies have highlighted numerous challenges with medicines use for patients with vision impairment, but evidence is lacking on interventions to support safe and effective medicine use for this population. This study aimed to identify potential barriers/facilitators of medicines use from the viewpoint of patients ...
Basma Y. Kentab, Heather E. Barry, Sinaa A. Al‐Aqeel, Carmel M. Hughes   +3 more
wiley   +1 more source

Comparative study to assess efficacy and safety of brinzolamide1% and timolol0.5% fixed combination eye drops versus dorzolamide2% and timolol0.5% fixed combination eye drops in management of open-angle glaucoma

Journal of Family Medicine and Primary Care, 2022
Aim and Objective: To compare the efficacy and safety of brinzolamide1% and timolol0.5% fixed combination eye drops versus dorzolamide2% and timolol0.5% fixed combination eye drops in the treatment of primary open-angle glaucoma.
Prerana Agarwal, Suryadev Tayal, Ankur Gautum   +2 more
doaj   +1 more source